SLC3A2 and neoplasm: CD8+T cells activated by anti-PD-L1 immunotherapy secrete IFN-γ, which significantly down-regulates the expression of SLC3A2 and SLC7A11 in tumor cells, resulting in the decrease of cystine uptake, thus promoting the occurrence of ferroptosis.